Compare AGRZ & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGRZ | ICCM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | Malaysia | Israel |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 43.4M |
| IPO Year | 2025 | N/A |
| Metric | AGRZ | ICCM |
|---|---|---|
| Price | $0.43 | $0.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 373.1K | 326.3K |
| Earning Date | 02-10-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2038.10 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $14,879,848.00 | $2,975,000.00 |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | $4.30 | ★ N/A |
| Revenue Growth | ★ 200.67 | N/A |
| 52 Week Low | $0.42 | $0.58 |
| 52 Week High | $7.20 | $1.66 |
| Indicator | AGRZ | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 44.10 |
| Support Level | N/A | $0.63 |
| Resistance Level | N/A | $0.71 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 18.92 |
Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.